BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Company received U.S. Food and Drug Administration (“FDA”) approval for the Abbreviated New Drug Application for Rifabutin Capsules USP, 150 mg.
Novitium Pharma`s Generic Rifabutin Receives Approval in the U.S.
TEL-AVIV, Israel and RALEIGH, N.C., July 27, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that EnvisionRx, a Pharmacy Benefit Manager (PBM) and division of EnvisionRxOptions, a wholly owned subsidiary of Rite Aid, added Talicia® (omeprazole magnesium, amoxicillin and rifabutin)1 to its Formularies, as the unrestricted branded agent for H. pylori treatment, effective July 1, 2020.
TEL-AVIV, Israel and RALEIGH , N.C., April 28, 2020, RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that Prime Therapeutics, a pharmacy benefit manager (PBM) serving 23 Blue Cross and Blue Shield Plans and more than 30 million members nationally, added Talicia® (omeprazole magnesium, amoxicillin and rifabutin)1 to the NetResults™ A-Series National Formulary as an unrestricted, preferred brand for H.pylori treatment, effective July 1, 2020.